This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLinked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLinkEN - EnglishSelect a languageLanguagesEN - EnglishFR - FrançiasSearch

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page
HomeHomeVaccines HomepageLoadingDisease AreasDisease AreasRespiratory Syncytial Virus (RSV)Tick-borne encephalitis (TBE)Disease Areas

Menu

Close

Our BrandsOur BrandsBrand Pages and Prescribing InformationABRYSVO®▼ (respiratory syncytial virus vaccine (bivalent, recombinant))TicoVac® (tick-borne encephalitis vaccine (whole virus inactivated))Prescribing InformationNimenrix® (meningococcal groups A, C, W-135 and Y conjugate vaccine)Prevenar 13® (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed))Trumenba® (meningococcal group B vaccine (recombinant, adsorbed))Vaccine TechnologiesVaccine TechnologiesMaternal ImmunisationInactivated VaccinesSupport & ResourcesSupport & Resources

Prescribing Information can be found at the bottom of the page.

Welcome to Pfizer Vaccines

Select a therapy area below to find out more about the infectious diseases, treatments and prevention methods that are impacted by our Pfizer Vaccine portfolio.

Respiratory Syncytial Virus (RSV)

Uncover this 'hidden annual epidemic' with our global RSV Experts in a series of short videos.1

Watch NowLoading

Tick-borne encephalitis (TBE)

Find out more about how ticks carry TBE, which parts of the globe are affected and how you can advise about prevention of infection.

Explore TBELoadingVaccine Technologies:

Maternal Immunisation

Learn about the mechanism of maternal immunisation and how immunising pregnant people can help to protect young infants.

Explore
Maternal
Immunisation
Loading

Inactivated Vaccines

 

Understand the mechanism of inactivated vaccines and why they are used to give protection. 

Explore
Inactivated 
Vaccines
LoadingOur Brands:Explore ABRYSVO® Loading Get to know Prevenar 13®LoadingDiscover TicoVac®LoadingMore on Nimenrix®LoadingLearn about Trumenba®Loading Register to receive personalised marketing information from Pfizer by email

Register to receive personalised marketing information from Pfizer by email

Sign up hereLoading

Prescribing Information

ABRYSVO®▼(Respiratory Syncytial Virus Vaccine [bivalent, recombinant])
Prevenar 13 (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed))
Nimenrix (meningococcal groups A, C, W-135 and Y conjugate vaccine)
TicoVac (Tick-Borne Encephalitis Vaccine (whole Virus, inactivated)) 0.5 ml Suspension for injection in a prefilled syringe
TicoVac Junior (Tick-Borne Encephalitis Vaccine (whole Virus, inactivated)) 0.25 ml Suspension for injection in a pre-filled syringe
Trumenba (meningococcal group B vaccine (recombinant, adsorbed))References:
  1. Public Health England. The Green Book [published 2013; updated 2020]. Chapter 25: Pneumococcal. Available at https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25 Last accessed: May 2022
  2. UPDATE REFERENCES

References:

National Foundation for Infectious Diseases. RSV: The Annual Epidemic You May Not Know About (But Should). National Foundation for Infectious Diseases (online). Updated: 30 November 2016. Accessed: April 2025. https://www.nfid.org/rsv-the-annual-epidemic-you-may-not-know-about-but-should/
PP-A1G-GBR-0371. April 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2025 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-11245. January 2025
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024.

YesNo
You are now leaving PfizerPro​​​​​
​
You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.

PP-UNP-GBR-12070. April 2025​​​​​​​
​​​​​​​
You are now leaving PfizerPro

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer's medicines or business which it has provided or reviewed.

PP-UNP-GBR-12107. April 2025
​​​​​​​